Work

Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease

Year: 2022

Type: article

Source: Heart Failure Clinics

DOI: 10.1016/j.hfc.2022.03.011

Authors: Husam M. Salah, Marat Fudim

Institutions: University of Arkansas for Medical Sciences, Duke University, Duke Clinical Research Institute

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Heart Association, National Heart, Lung, and Blood Institute

Awards: G3053555474, Is Heart Failure with Preserved Ejection Fraction the Symptomatic Manifestation of Liver Disease?

OpenAlex ID: W4303476216

FWCI: 0.915

Cites: 63

Cited by: 6

Related to: 10